We conduct trials with the highest standards of safety
Our trials are approved and monitored by the MHRA (Medicines and Healthcare products Regulatory Agency), and they look at every detail of our processes including staff training, our facilities and all our quality procedures before we can be recognised as a suitable unit for clinical trials.
An independent ethics committee also looks at all aspects of a new trial and will act to safeguard the rights, safety and well-being of volunteers who wish to take part.
Our staff are here to support and guide you throughout your experience and you can ask as many questions as you like before you come in for your trial, and during your stay.
All pharmaceutical companies must submit all relevant data to regulators as part of the approval process for new medicines. The HRA is also responsible for protecting and promoting the interests of patients and the public in health research seeking to improve public confidence.
All our clinical trials follow EU Regulations
All clinical trials performed in the European Union must be conducted in accordance with the EU Clinical Trials Directive issued by the European Parliament and of the Council.
The Clinical Trials Regulation aims to create an environment that is favourable for conducting clinical trials, with the highest standards of patient safety, for all EU Member States.
Working together to protect your safety
All our clinical trials have to be approved by an independent ethics committee. These are independent groups made up of a mixture of health professionals and non-medical people. They ensure patients are given all the information they need. Data monitoring committees monitor the safety of a clinical trial and how well a treatment is working. They can stop a trial if it is causing harm to a person. All clinical trials have some form of insurance to compensate patients in the unlikely event something goes wrong.